New study from Switzerland will allow for a better understanding of corneal cross-linking
Investigative Ophthalmology & Visual Science.
New research from ELZA members opens up new alleys to study the molecular events underlying corneal cross-linking.
“By being able to study the effect of CXL in the mouse, we now have a powerful tool to investigate the underlying molecular changes that occur during cross-linking. Hopefully,this will help to develop new treatment strategies to make CXL even more efficient”
, says Farhad Hafezi, Medical Director of the ELZA Institute, and Professor of Ophthalmology at the Universities of Geneva, Switzerland, and USC Los Angeles, USA. Read the article here.